Suggestion of new possibilities in approaching individual variability in appetite through constitutional typology: a pilot study

BMC Complementary and Alternative Medicine

Hyeung-Jin Jang¹  Byunghee Koh²  Euiju Lee²  Ki-Suk Kim¹  Hyunshang Shin²  Jiwon Lee²  Junhee Lee² 

[1] Department of Biochemistry, College of Oriental Medicine, Kyung Hee University, #1 Heogi-dong, Dongdaemun-gu, Seoul 130-701, Republic of Korea;Department of Sasang Constitutional Medicine, College of Oriental Medicine, Kyung Hee University

关键词: Sasang constitutional typology;    Eating behavior;    Appetite;    Gut hormone;   

Others  :  1232093
DOI  :  10.1186/1472-6882-12-122

 received in 2011-12-22, accepted in 2012-08-05,  发布年份 2012

【 摘 要 】

Background

Appetite is intricately connected to eating behaviors and shows a high individual variability. In an attempt to approach the problem of gut hormone profiles, appetite, and eating behaviors at the individual level, we have adopted a constitutional typing system widely used in traditional East-Asian medicine, the Sasang constitutional typology, in order to determine the individual variations in appetite, eating behavior, and weight change.

Methods

This pilot study was designed to investigate the variability of appetite among individuals by tracking the gut hormone patterns across different constitutional types. Pre- and post-prandial concentrations of anorectic (peptide YY (PYY), glucagon-like peptide 1 (GLP-1)) and orexigenic (active ghrelin) gut hormones were measured in healthy, normal-weight (18.5 kg/m² ≤BMI <23 kg/m²) male subjects aged 20–35 (Soyang (SY) (n = 9), Taeeum (TE) (n = 9), and Soeum (SE) (n = 10) constitutional types).

Results

Significant differences were found only in the PYY concentrations across the three groups (p = 0.031). The PYY concentration peaked at 30-min post-prandial in the SE group and was significantly higher compared to the other two groups (p = 0.004). The GLP-1 concentration peaked at 15-min post-prandial in the SE group (not significant). The ghrelin levels at 30-min pre-prandial were relatively lower in the TE group compared to the other groups (not significant).

Conclusions

In conclusion, although with weak statistical power, meaningful gut hormone patterns specific to each constitutional type were discovered in this pilot study, which could offer a new method of approaching the problem of appetite and eating behavior from the angle of individual variability in appetite.

【 授权许可】

   
2012 Lee et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Karra E, Batterham RL: The role of gut hormones in the regulation of body weight and energy homeostasis. Mol Cell Endocrinol 2010, 316(2):120-128.
• [2]Neary MT, Batterham RL: Gut hormones: implications for the treatment of obesity. Pharmacol Ther 2009, 124(1):44-56.
• [3]Hameed S, Dhillo WS, Bloom SR: Gut hormones and appetite control. Oral Dis 2009, 15(1):18-26.
• [4]Depoortere I, De Clercq P, Svoboda M, Bare L, Peeters TL: Identification of motilin mRNA in the brain of man and rabbit. Conservation of polymorphism of the motilin gene across species. Peptides 1997, 18(10):1497-1503.
• [5]Park S, Rew J, Lee S, Ki H, Lee K, Cheo J, Kim H, Noh D, Joo Y, Kim H, et al.: Association of CCK(1) Receptor Gene Polymorphisms and Irritable Bowel Syndrome in Korean. J Neurogastroenterol Motil 2010, 16(1):71-76.
• [6]Lavebratt C, Alpman A, Persson B, Arner P, Hoffstedt J: Common neuropeptide Y2 receptor gene variant is protective against obesity among Swedish men. Int J Obes 2006, 30(3):453-459.
• [7]Song I, Koh B, Lee E, Kim K, Kim D, Park S, et al.: Sasang Constitutional Medicine. Seoul: Jipmoondang; 2004.
• [8]Kim JY, Pham DD: Sasang constitutional medicine as a holistic tailored medicine. Evid Based Complement Alternat Med 2009, 6(Suppl 1):11-19.
• [9]Lee J, Jung Y, Yoo J, Lee E, Koh B: Perspective of the human body in sasang constitutional medicine. Evid-based Complement Altern Med 2009, 6(Suppl 1):31-41.
• [10]Kim E, Kim J: A clinical study on the Sasang constitution and obesity. J Sasang Constitut med 2004, 16(1):100-111.
• [11]Lee K, Seok J, Kim S, Kim Y, Lee S, Lee E, Kim D, Koh B: A case - control study on risk factors of obese patients of each Sasang constitution. J Sasang Constitut med 2007, 19(2):94-112.
• [12]Choi K, Yoo J, Lee E, Koh B, Lee J: Sasang constitutional types can act as a risk factor for insulin resistance. Diabetes Res Clin Pract 2011, 91(3):e57-e60.
• [13]Yin CS, Park HJ, Chung JH, Lee HJ, Lee BC: Genome-wide association study of the four-constitution medicine. J Altern Complement Med 2009, 15(12):1327-1333.
• [14]Kim M, Yoo J, Koh S, Park J: Prevalence of hypertension and risk factors according to Sasang constitution. J Sasang Constitut med 2009, 21(1):150-164.
• [15]Lee T, Hwang M, Lee S, Choe B, Song I: A study on the prevalence and risk factors of the metabolic syndrome according to Sasang constitution. J Korean Oriental Med 2006, 27(2):14-22.
• [16]Hwang M, Lee S, Choe B, Song I, Koh B: The research on the Sasang constitutional characteristics of stroke inpatients. J Sasang Constitut med 2005, 17(1):103-119.
• [17]Hwang M, Lee T, Lee S, Song I, Choe B, Koh B: The case–control study of ischemic stroke according to Sasang constitution. J Korean Oriental Med 2006, 27(1):118-129.
• [18]Park G, Lee J, Lee S, Lee E, Kim D, Song I, Koh B: The study on the actual nutrient intake based on Sasang constitution. J Sasang Constitut med 2007, 19(3):188-205.
• [19]Welch G, Thompson L, Hall A: The BULIT-R: its reliability and clinical validity as a screening tool for DSM-III-R bulimia nervosa in a female tertiary education population. Int J Eat Disord 1993, 14(1):95-105.
• [20]Garner DM, Garfinkel PE: The eating attitudes test: an index of the symptoms of anorexia nervosa. Psychol Med 1979, 9(2):273-279.
• [21]Svedlund J, Sjodin I, Dotevall G: GSRS–a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988, 33(2):129-134.
• [22]Kim H, Lee I, Kim J: A study of the reliability and validity of the korean version of the eating behavior questionnaire. Kor J Clin Psychol 1996, 15(1):141-150.
• [23]Wardle J: Eating style: a validation study of the dutch eating behaviour questionnaire in normal subjects and women with eating disorders. J Psychosomat Res 1987, 31(2):161-169.
• [24]Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR: Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 1985, 89(5):1070-1077.
• [25]le Roux CW, Batterham RL, Aylwin SJ, Patterson M, Borg CM, Wynne KJ, Kent A, Vincent RP, Gardiner J, Ghatei MA, et al.: Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 2006, 147(1):3-8.
• [26]Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, et al.: A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996, 379(6560):69-72.
• [27]Orskov C, Holst JJ, Nielsen OV: Effect of truncated glucagon-like peptide-1 [proglucagon-(78–107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach. Endocrinology 1988, 123(4):2009-2013.
• [28]Young AA, Gedulin BR, Rink TJ: Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7–36) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake. Metab Clin Exp 1996, 45(1):1-3.
• [29]Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS: A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001, 50(8):1714-1719.
• [30]le Roux CW, Patterson M, Vincent RP, Hunt C, Ghatei MA, Bloom SR: Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects. J Clin Endocrinol Metab 2005, 90(2):1068-1071.
• [31]Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K, Matsukura S: Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002, 87(1):240-244.
• [32]Um JY, Kim HM, Mun SW, Song YS, Hong SH: Interleukin-1 receptor antagonist gene polymorphism and traditional classification in obese women. Int J Neurosci 2006, 116(1):39-53.
• [33]Song J, Jeong H, Kim S, Son M, Na H, Song Y, Hong S, Kim H, Um J: Interleukin-1alpha polymorphism -889C/T related to obesity in Korean Taeumin women. Am J Chin Med 2008, 36(1):71-80.
• [34]Lee J, Kwon Y, Hong S, Jeong H, Kim H, Um J: Interleukin-1 beta gene polymorphism and traditional constitution in obese women. Int J Neurosci 2008, 118(6):793-805.